Markets
ACRS

Aclaris Therapeutics Appoints Jesse Hall As CMO

April 29, 2025 — 07:47 am EDT

Written by RTTNews.com for RTTNews->

(RTTNews) - Aclaris Therapeutics, Inc. (ACRS), a clinical-stage biopharmaceutical company, on Tuesday announced the appointment of Jesse Hall as Chief Medical Officer. The transition is effective May 1.

Hall has decades of experience in all phases of drug development. Hall most recently worked as Chief Medical Officer at AltruBio.

On Monday, Aclaris had closed 1.49% higher at $1.36 on the Nasdaq.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

Stocks mentioned

ACRS

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.